Correlation Between Quantum Genomics and Innate Pharma

Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quantum Genomics SA and Innate Pharma, you can compare the effects of market volatilities on Quantum Genomics and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and Innate Pharma.

Diversification Opportunities for Quantum Genomics and Innate Pharma

-0.03

Correlation Coefficient

Quantum Genomics  Innate Pharma

Good diversification

The 3 months correlation between Quantum and Innate is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and Innate Pharma go up and down completely randomly.

Pair Corralation between Quantum Genomics and Innate Pharma

If you would invest  142.00  in Innate Pharma on September 28, 2024 and sell it today you would earn a total of  53.00  from holding Innate Pharma or generate 37.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Quantum Genomics SA  vs.  Innate Pharma

Quantum Genomics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Quantum Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Innate Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Innate Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical indicators, Innate Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Quantum Genomics and Innate Pharma

The main advantage of trading using opposite Quantum Genomics and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.

The idea behind Quantum Genomics SA and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.